In a randomised , multicentre , double-blind phase @ trial in @ centres in @ countries , we enrolled patients who had locally advanced or metastatic non-small-cell lung cancer , progression after one or two previous regimens of chemotherapy , Eastern Cooperative Oncology Group ( ECOG ) performance status of @-@ , and presence of measurable disease .